Comment on BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients. Sekar D. Oral Oncol 2024;152:106812.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sekar D. Comment on BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients. Oral Oncol 2024;152:106812.
PMID: 38640747